Article: Lilly Announces Liver Safety Update/Straterra.

Date: December 17, 2004 
 
 
For Release: Immediately 
 
Refer to: Jennifer Bunselmeyer 
 
(317) 997-1755 (cell) 
 
(888) 462-2576 (pager) 
 
Bunselmeyer_Jennifer@Lilly.com 
 
 
Lilly Announces Important Liver Safety Update to Strattera(R) Label 
 
Indianapolis, IN, December 17, 2004 - Eli Lilly and Company announced today 
that it has added a bolded warning to the product label for Strattera, an 
attention deficit/hyperactivity disorder (ADHD) medication.  The bolded warning 
indicates that the medication should be discontinued in patients with jaundice 
(yellowing of the skin or whites of the eyes) or laboratory evidence of liver 
injury.  This label change discusses two reported ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!